WHO suspends Bharat's hep B vaccine, halts prequalification evaluation of other Bharat products
This article was originally published in Scrip
Executive Summary
The World Health Organisation has suspended the supply of Bharat Biotech's hepatitis B vaccine Revac-B+ through United Nations procuring agencies as a 'precautionary and interim' measure, after one of the firm's Indian facilities failed to meet GMP standards.